Treatment of neurocysticercosis: current status and future research needs - sprookjes - yvandenbroek - TriplyDB

Treatment of neurocysticercosis: current status and future research needs

Treatment of neurocysticercosis: current status and future research needs

http://www.wikidata.org/entity/Q34071278

about

Neurocysticercosis: a review Managing neurocysticercosis: challenges and solutions Immunology of Taenia solium taeniasis and human cysticercosis Conservative management of neurocysticercosis in a patient with hematopoietic stem cell transplantation: a case report and review Post-treatment vascular leakage and inflammatory responses around brain cysts in porcine neurocysticercosis Mixed cestode infection: an incidental association in an immunocompetent person.Neglected parasitic infections in the United States: cysticercosis.Lumbar spinal intradural neurocysticercosis: A case report.Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole.Helminth induced suppression of macrophage activation is correlated with inhibition of calcium channel activity Disruption of the blood-brain barrier in pigs naturally infected with Taenia solium, untreated and after anthelmintic treatment.A cross-sectional study of people with epilepsy and neurocysticercosis in Tanzania: clinical characteristics and diagnostic approaches Medical management of neurocysticercosis.Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.Solitary cysticercus granuloma.Sensitive in vitro system to assess morphological and biochemical effects of praziquantel and albendazole on Taenia solium cysts.Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy.Hemorrhagic cerebrovascular events and neurocysticercosis: a case report and review of the literature.Seizure in people with newly diagnosed active or transitional neurocysticercosis.STAT6⁻/⁻ mice exhibit decreased cells with alternatively activated macrophage phenotypes and enhanced disease severity in murine neurocysticercosis.Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity Inhibition of store-operated calcium entry in microglia by helminth factors: implications for immune suppression in neurocysticercosis Short report: A calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features Progesterone induces mucosal immunity in a rodent model of human taeniosis by Taenia solium.Prevalence of Neurocysticercosis in People with Epilepsy in the Eastern Province of Zambia.Inflammation Caused by Praziquantel Treatment Depends on the Location of the Taenia solium Cysticercus in Porcine Neurocysticercosis.Diagnosis and treatment of neurocysticercosis.Transient cortical blindness as a manifestation of solitary cysticercus granuloma.Epigenetic Modulation of Microglial Inflammatory Gene Loci in Helminth-Induced Immune Suppression: Implications for Immune Regulation in Neurocysticercosis Reduced Leukocyte Infiltration in Absence of Eosinophils Correlates with Decreased Tissue Damage and Disease Susceptibility in ΔdblGATA Mice during Murine Neurocysticercosis.In vitro analysis of albendazole sulfoxide enantiomers shows that (+)-(R)-albendazole sulfoxide is the active enantiomer against Taenia solium A new parasiticidal compound in T. solium cysticercosis.Advances in the diagnosis and management of neurocysticercosis.Increased accumulation of regulatory granulocytic myeloid cells in mannose receptor C type 1-deficient mice correlates with protection in a mouse model of neurocysticercosis.Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.The immune response in Taenia solium cysticercosis: protection and injury.Corticosteroid use in neurocysticercosis MyD88-deficient mice exhibit decreased parasite-induced immune responses but reduced disease severity in a murine model of neurocysticercosis.Progesterone induces scolex evagination of the human parasite Taenia solium: evolutionary implications to the host-parasite relationship Do helminths cause epilepsy?

P2860

Q24606075-9EF62C3C-2335-4D45-B4F8-0D69DAE5E33D Q26777315-2333B7D5-6F26-4AA1-B646-51F5E56EE712 Q26864296-7AC0CD4E-D707-4726-B01D-0584B905C237 Q27015925-75870E44-3C75-49FD-8BC7-5CDB0DA6A132 Q28544390-7EB737E1-FC0B-4BF5-AE7F-045BCD2A3B9F Q30404247-15AD55D0-1528-43E1-9BDF-4A2878517175 Q33588459-D117E852-9A13-4F6A-A280-9EF47D575EDB Q33745037-0B6ADA74-EE41-4E2E-B32A-C20B4ABDC8A0 Q33797550-9A693AB7-1169-4BB9-A0D6-1269991A625C Q33889610-EF353736-C0C8-412C-9456-D8E7965045AD Q33893112-F434F825-1029-4A95-9A99-FCC9F5E11357 Q33930522-8A043C19-DD2F-479E-B732-4B247BC77540 Q34074147-9293B611-EC45-479C-9041-1EC01D7C72D4 Q34150372-CA3CD895-23A9-4D78-9544-90D12E1371E9 Q34306018-F6EC2CA4-0059-4289-AB7F-098B80EE70CB Q34483571-86295775-7C81-46D1-92AC-8652358DCBBD Q34554210-3A303EBF-4F34-415F-BB00-F63B382483A7 Q34592179-43FE7F2E-E082-4F73-B4B3-DC991B2CA4E4 Q34675034-2257C16E-A507-43F7-9D84-56F92AD5C557 Q34776805-3E11939D-30A6-43FD-BE0A-3FE255F3DF35 Q34830010-BD90EECC-60FD-4F28-9743-62C3EF9F4801 Q34998744-1F76D427-D2A9-4620-8FA5-AFE70168647C Q35186817-C7B2478B-4C37-432C-AA58-2EFB15ECC571 Q35566870-4C59E3D1-373E-491D-A66E-9EB3692E5736 Q35748932-C02034C0-0106-400E-9F4A-95C824DA3510 Q35866736-205EE073-8B26-4434-88CA-329D62306E60 Q35953198-179E2A9A-D259-4A4B-A9C5-165C34103C03 Q35979512-D4B1A5B4-E13D-4734-9883-16785D872666 Q36003478-CEB051D0-E082-4E1D-9375-A6C66F5452C2 Q36058829-77F0FBAF-6C3F-4D5D-AD99-D75F323C9146 Q36558405-3D8221CF-7AE1-40E8-80F6-DF9A4ED95820 Q36665160-0145761B-3A76-4D73-9A61-E8AC78C5FAEA Q36688967-933C7A62-1B01-4AE3-B342-7E9448651124 Q36804752-081596C5-1B8C-41A5-AA84-6FF235DB9D54 Q36915099-1CDB93C0-7BD1-41E4-B2FE-BD82A139DF74 Q37016245-294BB29C-DC50-4DE1-8CB0-64450CA7272E Q37039999-765BB9EF-8895-4CB0-AE61-7B119E59EF2A Q37451102-066B24F3-6B39-4DB8-B459-96883958FA96 Q37485397-C7920195-DF4E-45F7-8CBB-C4263801E4C0 Q37613778-C90F0F3C-D142-4849-89C0-6325FB24B2A1

P2860

Treatment of neurocysticercosis: current status and future research needs

http://www.wikidata.org/entity/Q34071278

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Treatment of neurocysticercosis: current status and future research needs

@ast

Treatment of neurocysticercosis: current status and future research needs

@en

Treatment of neurocysticercosis: current status and future research needs

@nl

type

label

Treatment of neurocysticercosis: current status and future research needs

@ast

Treatment of neurocysticercosis: current status and future research needs

@en

Treatment of neurocysticercosis: current status and future research needs

@nl

prefLabel

Treatment of neurocysticercosis: current status and future research needs

@ast

Treatment of neurocysticercosis: current status and future research needs

@en

Treatment of neurocysticercosis: current status and future research needs

@nl

P1433

Q34071278-52C34613-25BF-48AF-B32A-7601D0F4661E

P1476

Q34071278-5040E79E-FBEE-447F-99D0-D2400F398FAE

P2093

Q34071278-01CD7CF7-500A-4A0E-809D-FDB415F8B610

Q34071278-0E4B03F1-E768-422F-B932-77A712E91B80

Q34071278-1CE13DFF-B096-4B9D-B4A1-2160EC9F2631

Q34071278-3F80BE0E-86E8-49AD-96AD-24B79DDD1971

Q34071278-42CAB103-F099-49A2-BAA1-B46716D87EF0

Q34071278-4D40DBC2-7DF8-408C-8CBE-11A1C8E44F86

Q34071278-54213ADD-02FC-47FF-BCF9-C2DF2B0C0AB5

Q34071278-558C3D21-A5F6-4BE7-A1D9-D10E27B11CA9

Q34071278-6A429612-D2A0-4799-A2FA-17067ACC8901

Q34071278-89A7BC0F-C458-4CE7-9E2E-AF45D7CAB6E9

P2860

Q34071278-03CED906-23AF-4166-844E-F0692AF8B020

Q34071278-06379D58-1A64-4D62-A5CB-F91579A3D5E8

Q34071278-0A89B56C-B689-48FA-9B1C-F6B34AD6F336

Q34071278-0C7A6A09-2B37-4E16-BA31-CA83AE939133

Q34071278-0E21400A-0A49-4756-912D-185AACA39F17

Q34071278-0EAA5EBF-4073-4E82-B270-F67F34009ADC

Q34071278-12D36D53-D75E-45C3-95C9-863CE7FC713C

Q34071278-17059C4A-6136-4378-AE66-C15C5BEE92D5

Q34071278-21C2CC55-9FC2-4B8A-964E-F6FE7F7F474F

Q34071278-266EEC9D-A900-4FED-A617-027B58C2E26A

P304

Q34071278-30EE315F-3CC3-417D-9C8F-06BE0B571634

P31

Q34071278-41325FEE-3A54-45BB-9C86-A098A7021A39

P356

Q34071278-BF316A75-58B7-4586-9B6D-DAFA14D8F1B3

P407

Q34071278-F5954931-6ABD-482A-B69E-8A9B3BF8B298

P433

Q34071278-9DB93F62-746C-4FA9-AE12-E1B7C8CC531E

P478

Q34071278-9AA515EB-C348-4343-A6EF-01DDA1227E9E

P50

Q34071278-09DE2998-79EA-42B4-87CD-96A0E227C885

Q34071278-34511A55-94C1-4D0C-BB01-06E7F4796B72

Q34071278-350F89D5-4CC1-420C-810B-C92E4F674A1D

Q34071278-80CEF34C-AFE5-49FF-A5B0-27F7CAC444A1

Q34071278-DFA84967-EE3C-4D08-A8F7-4A69528E63CB

P577

Q34071278-2F45723E-0790-4F3D-A2A8-5CC0A47460CB

P5875

Q34071278-E09A92AD-EF25-4F92-963E-8ACAEFFA77A3

P698

Q34071278-2463A257-D656-4B9D-AD8F-1BD91098B8F0

P921

Q34071278-DCD4C774-9044-4BB1-978C-107863EFD96C

P932

Q34071278-FE5DE8CF-220F-4E5E-A08B-7E9790C5E3A1

P356

01.WNL.0000238514.51747.3A

P1433

P1476

Treatment of neurocysticercosis: current status and future research needs

@en

P2093

C A W Evans

http://www.w3.org/2001/XMLSchema#string

C DeGiorgio

http://www.w3.org/2001/XMLSchema#string

E J Pretell

http://www.w3.org/2001/XMLSchema#string

G Singh

http://www.w3.org/2001/XMLSchema#string

H H Garcia

http://www.w3.org/2001/XMLSchema#string

J A Loeb

http://www.w3.org/2001/XMLSchema#string

J Teale

http://www.w3.org/2001/XMLSchema#string

J V Proaño

http://www.w3.org/2001/XMLSchema#string

O H Del Brutto

http://www.w3.org/2001/XMLSchema#string

O M Takayanagui

http://www.w3.org/2001/XMLSchema#string

P2860

Neurocysticercosis: a major cause of neurological disease worldwide

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

Endoscopic management of cysticercal cysts within the lateral and third ventricles.

Imaging findings in neurocysticercosis.

Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis.

Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients.

Perilesional gliosis and seizure outcome: a study based on magnetization transfer magnetic resonance imaging in patients with neurocysticercosis.

Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.

Calcific neurocysticercosis and epileptogenesis.

A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis.

P304

1120-1127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/01.WNL.0000238514.51747.3A

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P50

Armando E. Gonzalez

A Clinton White

Antonio V Delgado-Escueta

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6763963

http://www.w3.org/2001/XMLSchema#string

P698

17030744

http://www.w3.org/2001/XMLSchema#string

P921

neurocysticercosis

P932

2923067

http://www.w3.org/2001/XMLSchema#string